Apellis Pharmaceuticals Inc (APLS) stock news · rev $1.00B
Apellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
This APLS news page leads with what Apellis Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for APLS yet. We will not pad this page with generic market recap.
Latest reported APLS revenue for 2025-12-31 was $1.00B. Net income was $22.4M. Revenue was up 28.5% from 2024-12-31 to 2025-12-31. APLS currently screens at market cap $2.29B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the APLS stock page; for the tape open the quote page.
APLS stock news FAQ
What are APLS's latest revenue and net income?
Latest cached Apellis Pharmaceuticals Inc (APLS) revenue for Dec 31, 2025 was $1.00B. Net income was $22.4M. Statements: https://lician.com/financials/apls
How did APLS revenue change from the prior cached period?
Cached Apellis Pharmaceuticals Inc (APLS) revenue was up 28.5% from $781.4M (Dec 31, 2024) to $1.00B (Dec 31, 2025). Statements: https://lician.com/financials/apls
What is APLS's market cap?
Apellis Pharmaceuticals Inc (APLS) market cap is $2.29B on the latest cached fundamentals snapshot.
What kind of company is APLS?
Apellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
Where is APLS stock news listed?
Cached stock news for Apellis Pharmaceuticals Inc (APLS) is listed at https://lician.com/news/apls. Filings: https://lician.com/sec/apls
Not investment advice.